Insmed Interest Income from 2010 to 2024

INSM Stock

USD 75.88 0.20 0.26%

Insmed Interest Income yearly trend continues to be very stable with very little volatility. Interest Income is likely to drop to about 2.1 M. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2010-12-31

Previous Quarter

2.2 M

Current Value

2.1 M

Quarterly Volatility

5 M

Credit Downgrade

Yuan Drop

Covid

Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 85.8 M or Total Revenue of 320.5 M, as well as many indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 47.02. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.

Check out the analysis of Insmed Correlation against competitors.

Latest Insmed's Interest Income Growth Pattern

Below is the plot of the Interest Income of Insmed Inc over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Insmed's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Insmed Interest Income Regression Statistics

	Arithmetic Mean	4,382,959
	Geometric Mean	3,169,536
	Coefficient Of Variation	113.25
	Mean Deviation	3,219,878
	Median	2,628,000
	Standard Deviation	4,963,527
	Sample Variance	24.6T
	Range	15.9M
	R-Value	0.09
	Mean Square Error	26.3T
	R-Squared	0.01
	Significance	0.76
	Slope	95,755
	Total Sum of Squares	344.9T

Insmed Interest Income History

	2024	2.1 M
	2023	2.2 M
	2020	1.9 M
	2019	17.8 M
	2018	15.1 M
	2017	4.3 M
	2016	2.9 M

Other Fundumenentals of Insmed Inc

Net Interest Income

Insmed Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Good Will	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Short Term Debt	Long Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.34	0.59	-0.96	0.92	0.61	0.95	0.99	0.9	0.88	0.54	0.91	-0.68	0.91	-0.04	0.95	-0.49	0.97	0.44	0.93	0.6	0.95	0.93	0.93
Total Stockholder Equity	-0.34		-0.93	0.5	-0.57	-0.89	-0.62	-0.3	-0.14	-0.53	0.09	-0.34	0.39	-0.61	0.28	-0.62	0.88	-0.41	0.29	-0.66	-0.05	-0.25	-0.31	-0.53
Net Debt	0.59	-0.93		-0.73	0.78	0.97	0.81	0.54	0.39	0.76	0.13	0.6	-0.57	0.83	-0.25	0.81	-0.85	0.67	-0.09	0.84	0.21	0.49	0.51	0.74
Retained Earnings	-0.96	0.5	-0.73		-0.97	-0.75	-0.97	-0.94	-0.88	-0.9	-0.49	-0.94	0.66	-0.97	-0.01	-0.96	0.54	-0.99	-0.43	-0.96	-0.63	-0.84	-0.83	-0.94
Accounts Payable	0.92	-0.57	0.78	-0.97		0.79	0.96	0.9	0.81	0.88	0.41	0.88	-0.75	0.95	0.0	0.95	-0.6	0.95	0.34	0.95	0.54	0.8	0.8	0.93
Short Term Investments	0.61	-0.89	0.97	-0.75	0.79		0.81	0.57	0.43	0.78	0.22	0.59	-0.52	0.82	-0.17	0.8	-0.78	0.69	0.01	0.84	0.21	0.46	0.48	0.73
Total Liab	0.95	-0.62	0.81	-0.97	0.96	0.81		0.93	0.79	0.92	0.42	0.88	-0.7	0.97	-0.13	1.0	-0.7	0.95	0.27	1.0	0.52	0.87	0.88	0.95
Total Current Assets	0.99	-0.3	0.54	-0.94	0.9	0.57	0.93		0.91	0.84	0.52	0.9	-0.64	0.88	-0.02	0.93	-0.45	0.95	0.46	0.91	0.62	0.94	0.93	0.9
Common Stock	0.9	-0.14	0.39	-0.88	0.81	0.43	0.79	0.91		0.74	0.6	0.85	-0.53	0.78	0.16	0.79	-0.25	0.89	0.61	0.77	0.74	0.82	0.8	0.84
Good Will	0.88	-0.53	0.76	-0.9	0.88	0.78	0.92	0.84	0.74		0.65	0.74	-0.68	0.9	-0.08	0.91	-0.65	0.87	0.31	0.91	0.4	0.82	0.8	0.89
Intangible Assets	0.54	0.09	0.13	-0.49	0.41	0.22	0.42	0.52	0.6	0.65		0.37	-0.22	0.39	0.12	0.41	-0.14	0.46	0.45	0.39	0.3	0.48	0.46	0.42
Property Plant Equipment	0.91	-0.34	0.6	-0.94	0.88	0.59	0.88	0.9	0.85	0.74	0.37		-0.6	0.91	-0.02	0.87	-0.37	0.95	0.45	0.86	0.66	0.81	0.78	0.86
Current Deferred Revenue	-0.68	0.39	-0.57	0.66	-0.75	-0.52	-0.7	-0.64	-0.53	-0.68	-0.22	-0.6		-0.7	0.32	-0.69	0.51	-0.66	0.0	-0.69	-0.14	-0.74	-0.71	-0.8
Net Receivables	0.91	-0.61	0.83	-0.97	0.95	0.82	0.97	0.88	0.78	0.9	0.39	0.91	-0.7		-0.1	0.96	-0.64	0.95	0.3	0.97	0.49	0.81	0.8	0.94
Short Term Debt	-0.04	0.28	-0.25	-0.01	0.0	-0.17	-0.13	-0.02	0.16	-0.08	0.12	-0.02	0.32	-0.1		-0.13	0.36	0.04	0.57	-0.14	0.48	-0.13	-0.15	-0.13
Long Term Debt	0.95	-0.62	0.81	-0.96	0.95	0.8	1.0	0.93	0.79	0.91	0.41	0.87	-0.69	0.96	-0.13		-0.71	0.94	0.27	1.0	0.52	0.87	0.89	0.95
Net Tangible Assets	-0.49	0.88	-0.85	0.54	-0.6	-0.78	-0.7	-0.45	-0.25	-0.65	-0.14	-0.37	0.51	-0.64	0.36	-0.71		-0.45	0.32	-0.73	-0.11	-0.51	-0.59	-0.64
Capital Surpluse	0.97	-0.41	0.67	-0.99	0.95	0.69	0.95	0.95	0.89	0.87	0.46	0.95	-0.66	0.95	0.04	0.94	-0.45		0.49	0.94	0.64	0.86	0.83	0.92
Deferred Long Term Liab	0.44	0.29	-0.09	-0.43	0.34	0.01	0.27	0.46	0.61	0.31	0.45	0.45	0.0	0.3	0.57	0.27	0.32	0.49		0.25	0.47	0.3	0.24	0.25
Long Term Debt Total	0.93	-0.66	0.84	-0.96	0.95	0.84	1.0	0.91	0.77	0.91	0.39	0.86	-0.69	0.97	-0.14	1.0	-0.73	0.94	0.25		0.5	0.84	0.85	0.94
Short Long Term Debt	0.6	-0.05	0.21	-0.63	0.54	0.21	0.52	0.62	0.74	0.4	0.3	0.66	-0.14	0.49	0.48	0.52	-0.11	0.64	0.47	0.5		0.54	0.51	0.54
Net Invested Capital	0.95	-0.25	0.49	-0.84	0.8	0.46	0.87	0.94	0.82	0.82	0.48	0.81	-0.74	0.81	-0.13	0.87	-0.51	0.86	0.3	0.84	0.54		0.99	0.9
Net Working Capital	0.93	-0.31	0.51	-0.83	0.8	0.48	0.88	0.93	0.8	0.8	0.46	0.78	-0.71	0.8	-0.15	0.89	-0.59	0.83	0.24	0.85	0.51	0.99		0.89
Capital Stock	0.93	-0.53	0.74	-0.94	0.93	0.73	0.95	0.9	0.84	0.89	0.42	0.86	-0.8	0.94	-0.13	0.95	-0.64	0.92	0.25	0.94	0.54	0.9	0.89

Click cells to compare fundamentals

About Insmed Financial Statements

Insmed investors utilize fundamental indicators, such as Interest Income, to predict how Insmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Interest Income	2.2 M	2.1 M
Net Interest Income	-81.7 M	-77.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:

How To Invest In Insmed

Details

Is Insmed Stock a good investment?

Details

What is Insmed's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Insmed Correlation against competitors.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.55)

Revenue Per Share

2.206

Quarterly Revenue Growth

0.182

Return On Assets

(0.26)

Return On Equity

(8.91)

The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Insmed Interest Income from 2010 to 2024

Latest Insmed's Interest Income Growth Pattern

Insmed Interest Income Regression Statistics

Insmed Interest Income History

Other Fundumenentals of Insmed Inc

Insmed Interest Income component correlations

About Insmed Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY